O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+38.81%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11.4B
AUM Growth
+$11.4B
(+44%)
Cap. Flow
+$1.3B
Cap. Flow
% of AUM
11.42%
Top 10 Holdings %
Top 10 Hldgs %
37.61%
Holding
165
New
23
Increased
27
Reduced
20
Closed
17
Top Buys
| 1 |
ARS Pharmaceuticals
SPRY
|
$405M |
| 2 |
AbCellera Biologics
ABCL
|
$338M |
| 3 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$153M |
| 4 |
UnitedHealth
UNH
|
$137M |
| 5 |
Pfizer
PFE
|
$133M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$315M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$67.6M |
| 3 |
Ascendis Pharma
ASND
|
$66.4M |
| 4 |
Exelixis
EXEL
|
$58.8M |
| 5 |
Eledon Pharmaceuticals
ELDN
|
$46.7M |
Sector Composition
| 1 | Healthcare | 98.28% |
| 2 | Financials | 0.52% |
| 3 | Technology | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
51
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $64.2M | 0.56% | 1,125,700 | – | – |
|
52
MeiraGTx Holdings
MGTX
$587M
| $62.1M | 0.54% | 4,102,925 +389,105 | +10% | +$5.89M |
|
53
Enliven Therapeutics
ELVN
$1.2B
| $60M | 0.52% | 2,719,902 | – | – |
|
54
Adverum Biotechnologies
ADVM
$64.6M
| $59.6M | 0.52% | 5,501,144 +916,800 | +20% | +$9.94M |
|
55
eHealth
EHTH
$118M
| $59.6M | 0.52% | 844,046 +205,488 | +32% | +$14.5M |
|
|
CHNG
56
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $57.7M | 0.5% | 3,093,700 | – | – |
|
57
Stryker
SYK
$150B
| $57.6M | 0.5% | 235,000 | – | – |
|
|
58
Ascendis Pharma
ASND
$11.8B
| $56.1M | 0.49% | 336,500 -398,000 | -54% | -$66.4M |
|
59
Arcturus Therapeutics
ARCT
$462M
| $55.5M | 0.49% | 1,280,086 +661,500 | +107% | +$28.7M |
|
60
Acadia Healthcare
ACHC
$2.12B
| $52M | 0.46% | 1,035,160 -79,306 | -7% | -$3.99M |
|
61
Thermo Fisher Scientific
TMO
$186B
| $51.4M | 0.45% | 110,300 | – | – |
|
62
Galecto
GLTO
$4.21M
| $51.2M | 0.45% | +4,090,937 | New | +$51.2M |
|
|
MREO
63
Mereo BioPharma
MREO
$272M
| – | – | 0 | – | – |
|
64
TELA Bio
TELA
$70.5M
| $45.5M | 0.4% | 3,027,542 | – | – |
|
|
TRIL
65
DELISTED
Trillium Therapeutics Inc.
TRIL
| $43.5M | 0.38% | 2,960,200 +1,707,600 | +136% | +$25.1M |
|
66
SI-BONE Inc
SIBN
$719M
| $40.9M | 0.36% | 1,368,500 | – | – |
|
|
ATNX
67
DELISTED
Athenex, Inc. Common Stock
ATNX
| $40.9M | 0.36% | 3,694,061 -283,889 | -7% | -$3.14M |
|
|
VRNA
68
Verona Pharma
VRNA
$9.16B
| $39.9M | 0.35% | 5,694,841 | – | – |
|
69
Applied Therapeutics
APLT
$71M
| $39M | 0.34% | 1,771,831 +225,144 | +15% | +$4.96M |
|
70
Crinetics Pharmaceuticals
CRNX
$2.92B
| $38.9M | 0.34% | 2,753,567 | – | – |
|
|
ALPN
71
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $38.7M | 0.34% | 3,070,955 -600,000 | -16% | -$7.56M |
|
72
Xenon Pharmaceuticals
XENE
$2.98B
| $38.4M | 0.34% | 2,497,917 | – | – |
|
|
FUSN
73
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $37.9M | 0.33% | 3,224,770 | – | – |
|
74
KALA BIO
KALA
$78.8M
| $37.1M | 0.32% | 5,465,030 | – | – |
|
75
Curis
CRIS
$20.9M
| $35.8M | 0.31% | 4,366,494 +3,125,000 | +252% | +$25.6M |
|